Michael Sarcone
Stock Analyst at Jefferies
(n/a)
# 4,914
Out of 5,147 analysts
10
Total ratings
n/a
Success rate
-27.57%
Average return
Main Sectors:
Stocks Rated by Michael Sarcone
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSP Inspire Medical Systems | Maintains: Hold | $81 → $66 | $64.51 | +2.31% | 2 | Feb 12, 2026 | |
| AXGN Axogen | Maintains: Buy | $29 → $36 | $31.73 | +13.46% | 2 | Dec 4, 2025 | |
| ALGN Align Technology | Downgrades: Hold | $215 → $140 | $190.10 | -26.35% | 1 | Oct 10, 2025 | |
| EDAP EDAP TMS | Downgrades: Hold | $8 → $2 | $4.37 | -54.23% | 2 | Apr 4, 2025 | |
| PRCT PROCEPT BioRobotics | Initiates: Hold | $95 | $22.69 | +318.69% | 1 | Nov 14, 2024 | |
| GKOS Glaukos | Upgrades: Buy | $84 → $125 | $120.40 | +3.82% | 1 | May 6, 2024 | |
| PROF Profound Medical | Downgrades: Equal-Weight | $5.5 → $10 | $7.61 | +31.41% | 1 | Mar 21, 2023 |
Inspire Medical Systems
Feb 12, 2026
Maintains: Hold
Price Target: $81 → $66
Current: $64.51
Upside: +2.31%
Axogen
Dec 4, 2025
Maintains: Buy
Price Target: $29 → $36
Current: $31.73
Upside: +13.46%
Align Technology
Oct 10, 2025
Downgrades: Hold
Price Target: $215 → $140
Current: $190.10
Upside: -26.35%
EDAP TMS
Apr 4, 2025
Downgrades: Hold
Price Target: $8 → $2
Current: $4.37
Upside: -54.23%
PROCEPT BioRobotics
Nov 14, 2024
Initiates: Hold
Price Target: $95
Current: $22.69
Upside: +318.69%
Glaukos
May 6, 2024
Upgrades: Buy
Price Target: $84 → $125
Current: $120.40
Upside: +3.82%
Profound Medical
Mar 21, 2023
Downgrades: Equal-Weight
Price Target: $5.5 → $10
Current: $7.61
Upside: +31.41%